Please assess the completion status of the following clinical trial:

Trial Title: RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Cesarean Pain Relief

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age greater than or equal to 18 years~* Scheduled cesarean section delivery~* Patient of TriHealth's Faculty Medical Center or Tri-State Maternal Fetal Medicine Associates~* Singleton pregnancy~* Term delivery (greater than or equal to 37 weeks)~* Spinal/epidural anesthesia with epidural analgesia (duramorph)~* Use of pfannenstiel incision~Exclusion Criteria:~* Weight less than 50 kg~* Allergy to study drugs (acetaminophen, oxycodone, duramorph, NSAIDS)~* Multiple gestation pregnancy~* Cesarean section for pre-term delivery (less than 37 weeks)~* Fetal anomalies~* Inability to use epidural duramorph at time of procedure~* General anesthesia used~* Vertical skin incision~* Opioid addiction~* Liver dysfunction (hepatitis, HELLP (hemolysis, elevated liver enzymes, and low platelet count), preeclampsia)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- IV Acetaminophen (Type: EXPERIMENTAL): Subjects will receive a 1000mg dose of IV acetaminophen in 100mL solution every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.
- Normal Saline (Type: PLACEBO_COMPARATOR): Subjects will receive a 100mL dose of saline every 8 hours for 48 hours. The first dose will be administered intraoperatively following delivery of the baby. A total of 6 doses will be given.

Based on this trial design, predict the completion outcome and termination type (if applicable).